Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Influences on Attitudes regarding Potential COVID-19 Vaccination in the United States

Version 1 : Received: 13 September 2020 / Approved: 15 September 2020 / Online: 15 September 2020 (10:32:28 CEST)

How to cite: Pogue, K.; Jensen, J.; Stancil, C.; Ferguson, D.; Hughes, S.; Mello, E.; Burgess, R.; Berges, B.; Quaye, A.; Poole, B.D. Influences on Attitudes regarding Potential COVID-19 Vaccination in the United States. Preprints 2020, 2020090338 (doi: 10.20944/preprints202009.0338.v1). Pogue, K.; Jensen, J.; Stancil, C.; Ferguson, D.; Hughes, S.; Mello, E.; Burgess, R.; Berges, B.; Quaye, A.; Poole, B.D. Influences on Attitudes regarding Potential COVID-19 Vaccination in the United States. Preprints 2020, 2020090338 (doi: 10.20944/preprints202009.0338.v1).

Abstract

The COVID-19 pandemic continues to ravage the world, with the United States being highly affected. A vaccine provides the best hope for a permanent solution to controlling the pandemic. However, to be effective, a vaccine must be accepted and used by a large majority of the population. Structural equation modelling was used to analyze the relationships of several factors with attitudes toward potential COVID-19 vaccination. The survey was administered to 316 respondents across the United States by a survey corporation. Prior vaccine usage and attitudes predicted attitudes towards COVID-19 vaccination. Assessment of the severity of COVID-19 for the United States was also predictive. Approximately 68% of all respondents were supportive of being vaccinated for COVID-19, but side effects, efficacy, and length of testing remained concerns. Longer testing, increased efficacy and development in the United States were significantly associated with increased vaccine acceptance. Messages promoting COVID-19 vaccination should seek to alleviate the concerns of those who are already vaccine-hesitant. Messaging directed at the benefits of vaccination for the United States as a country would address the second predictive factor. Enough time should be taken to allay concerns about both short and long-term side effects before a vaccine is released.

Subject Areas

COVID-19; vaccine hesitancy; vaccine attitudes; vaccine development; SARS-CoV-2

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.